biotech

Latest news and analysis on biotech

The US transport sector and the biotech sector are two extremes of the US market

John Robertson
John Robertson
PortfolioDirect

There's some interesting action going on in US equities today

Jay Soloff
Jay Soloff
Argonath Financial

At least one patient with diabetic limb ulcers will be pleased that they participated in Osprey Medical's (ASX:OSP) Limb Recovery trial

Matthijs Smith
Matthijs Smith
Canaccord Genuity Australia

After Prana (ASX:PBT) announced a result we would rather forget from their Alzheimer's drug, the biotech sector closed down 7.9% last week

Matthijs Smith
Matthijs Smith
Canaccord Genuity Australia

dorsaVi (ASX:DVL) is walking around with an impressive update on the commercialisation of its movement products

Matthijs Smith
Matthijs Smith
Canaccord Genuity Australia

Last week, the small end of town was where all the action was in biotech-land with Biotron (ASX:BIT) up 97%, newcomer Innate Therapeutics (ASX:IIL) up 33% and...

Matthijs Smith
Matthijs Smith
Canaccord Genuity Australia

Morgans Research maintain an add recommendation on GI Dynamics (GID) with a price target of $1.61

Livewire Equities
Livewire Equities
Livewire

Innate Immunotherapeutics (IIL) listed late in 2013 with Australian Ethical taking a cornerstone position in the float

Livewire Equities
Livewire Equities
Livewire
81-88 of 88